Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Omeros reported $7.9M in Interest Expense on Debt for its fiscal quarter ending in December of 2022.

Interest Expense On Debt Change
Alnylam Pharmaceuticals ALNY:US USD 28.96M 958K
BioMarin Pharmaceutical BMRN:US USD 3.7M 77K
Gilead Sciences GILD:US USD 230M 3M
Insmed INSM:US USD 20.08M 3.63M
Intercept Pharmaceuticals ICPT:US USD 2.81M 3K
Knight Therapeutics Inc GUD:CN CAD 2.79M 498K
Pacira PCRX:US USD 9.59M 1.45M
Pfizer PFE:US USD 318M 5M
Rockwell Medical RMTI:US USD 387K 52K
Sarepta Therapeutics SRPT:US USD 6.32M 365K
United Therapeutics UTHR:US USD 13.8M 1.5M
Vertex Pharmaceuticals VRTX:US USD 11.4M 200K